AR006023A1 - VACCINE AGAINST SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME - Google Patents

VACCINE AGAINST SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME

Info

Publication number
AR006023A1
AR006023A1 ARP970100790A ARP970100790A AR006023A1 AR 006023 A1 AR006023 A1 AR 006023A1 AR P970100790 A ARP970100790 A AR P970100790A AR P970100790 A ARP970100790 A AR P970100790A AR 006023 A1 AR006023 A1 AR 006023A1
Authority
AR
Argentina
Prior art keywords
respiratory syndrome
vaccine against
against swine
vaccine
reproductive
Prior art date
Application number
ARP970100790A
Other languages
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR006023(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR006023A1 publication Critical patent/AR006023A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Abstract

Describe una vacuna y métodos para el tratamiento del síndrome reproductivo y respiratorios. La vacuna se obtiene del agente viral NEB-1-P94. Además,describe un virus de vacuna con características fenotípicas que puede distinguirse delviru s de PRRS de tipo cimarrón. Depósito en la Asociaciónamericana de Cultivos Tipo N° VR-2525.Describes a vaccine and methods for the treatment of reproductive and respiratory syndrome. The vaccine is obtained from the viral agent NEB-1-P94. Furthermore, it describes a vaccinia virus with phenotypic characteristics that can be distinguished from PRRS viruses of the bighorn type. Deposit in the American Association of Type Crops No. VR-2525.

ARP970100790A 1996-03-01 1997-02-27 VACCINE AGAINST SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME AR006023A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01

Publications (1)

Publication Number Publication Date
AR006023A1 true AR006023A1 (en) 1999-07-21

Family

ID=24442410

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100790A AR006023A1 (en) 1996-03-01 1997-02-27 VACCINE AGAINST SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME

Country Status (19)

Country Link
EP (1) EP0894007A1 (en)
JP (1) JP3135069B2 (en)
KR (1) KR100297537B1 (en)
CN (1) CN1165342C (en)
AR (1) AR006023A1 (en)
AU (1) AU2277497A (en)
BG (1) BG64693B1 (en)
BR (1) BR9708443B1 (en)
CA (1) CA2248182C (en)
CO (1) CO4600644A1 (en)
CZ (1) CZ273798A3 (en)
EE (1) EE04741B1 (en)
HU (1) HUP9901958A3 (en)
MY (1) MY115070A (en)
PL (1) PL328627A1 (en)
RU (1) RU2187333C2 (en)
SK (1) SK119498A3 (en)
WO (1) WO1997031651A1 (en)
ZA (1) ZA971663B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
NZ513289A (en) 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
CA2366072C (en) 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
MXPA01010681A (en) 1999-04-22 2003-08-20 Us Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142.
WO2006009880A2 (en) 2004-06-18 2006-01-26 Regents Of The University Of Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
PT2369001T (en) 2005-06-24 2016-10-25 Univ Minnesota Prrs viruses, infectious clones, mutants thereof, and methods of use
CN101612395B (en) * 2008-06-24 2012-02-08 扬州优邦生物制药有限公司 Method for producing blue-ear disease vaccine by culturing sensitive cell
TWI627281B (en) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 Methods of reducing viricidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity
MX345188B (en) 2011-02-17 2017-01-20 Boehringer Ingelheim Vetmedica Gmbh Novel european prrsv strain.
EP2675476B1 (en) 2011-02-17 2015-09-16 Boehringer Ingelheim Vetmedica GmbH Commercial scale process for production of prrsv
WO2013017568A1 (en) 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
KR101300528B1 (en) * 2011-10-05 2013-09-02 캔 테크놀로지스 인코포레이티드 Composition for prevention and treatment of Actinobacillus pleuropneumoniae infection
WO2014150822A2 (en) 2013-03-15 2014-09-25 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
EP4012025A1 (en) * 2020-12-10 2022-06-15 Univerzita Palackého v Olomouci Transport medium for samples containing nucleic acids and/or proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
CA2121241C (en) * 1991-10-14 2007-12-04 Nicolaas Visser Porcine reproductive respiratory syndrome vaccine and diagnostic
FR2686097B1 (en) * 1992-01-14 1994-12-30 Rhone Merieux PREPARATION OF ANTIGENS AND MYSTERY DISEASE VIRUS VACCINES, ANTIGENS AND VACCINES OBTAINED FOR THE PREVENTION OF THIS DISEASE.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
JP3710095B2 (en) * 1993-02-08 2005-10-26 バイエル・コーポレーシヨン Method for propagating porcine reproductive and respiratory syndrome virus and its use in vaccines
ES2074950B1 (en) * 1993-09-17 1996-03-16 Iberica Cyanamid VACCINE FOR THE PREVENTION OF REPRODUCTIVE AND RESPIRATORY DISEASE OF THE SOW.
DE69522984T2 (en) * 1994-04-11 2002-04-25 Akzo Nobel Nv Pig reproductive respiratory syndrome virus vaccine European strains
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
JP3135069B2 (en) 2001-02-13
CN1216922A (en) 1999-05-19
HUP9901958A3 (en) 2000-04-28
BR9708443B1 (en) 2012-06-12
EE9800267A (en) 1999-02-15
AU2277497A (en) 1997-09-16
MY115070A (en) 2003-03-31
CN1165342C (en) 2004-09-08
BG102809A (en) 1999-05-31
WO1997031651A1 (en) 1997-09-04
MX9807083A (en) 1998-12-31
KR19990087432A (en) 1999-12-27
HUP9901958A2 (en) 1999-10-28
CA2248182C (en) 2004-04-20
CO4600644A1 (en) 1998-05-08
BG64693B1 (en) 2005-12-30
PL328627A1 (en) 1999-02-15
RU2187333C2 (en) 2002-08-20
KR100297537B1 (en) 2001-10-26
EP0894007A1 (en) 1999-02-03
EE04741B1 (en) 2006-12-15
ZA971663B (en) 1997-08-26
CZ273798A3 (en) 1999-02-17
CA2248182A1 (en) 1997-09-04
JPH11506122A (en) 1999-06-02
BR9708443A (en) 1999-08-03
SK119498A3 (en) 1999-07-12

Similar Documents

Publication Publication Date Title
AR006023A1 (en) VACCINE AGAINST SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME
MX9204885A (en) VACCINE COMPOSITION INCLUDING VIRUSES OF INFERTILITY AND RESPIRATORY SYNDROME OF PIGS.
ES2157522T3 (en) EUROPEAN VACCINE VIRUSES OF THE SWINE REPRODUCTIVE RESPIRATORY SYNDROME (PRRSV).
UY26724A1 (en) METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUSES
DE69619233T2 (en) PRRS (PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME) VIRUS VACCINE
HUP9801124A2 (en) New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process
ES2074950B1 (en) VACCINE FOR THE PREVENTION OF REPRODUCTIVE AND RESPIRATORY DISEASE OF THE SOW.
TR200102308T2 (en) Artificial peptides with surface activity and their use in the preparation of artificial surfactants
TR200001842T2 (en) Papilloma virus capsomer vaccine formulations- methods of use.
AR020134A1 (en) IMMUNOLOGICAL ANTIGENS AGAINST THE SIMPLEX HERPES VIRUS AND METHODS FOR THE USE OF THE SAME
ATE131067T1 (en) VACCINE AGAINST SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) AND DIAGNOSIS.
TW200509961A (en) Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
EP1794329A4 (en) Porcine reproductive and respiratory syndrome isolates and methods of use
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
SE9602931L (en) New medical use
BR0212312A (en) Bovine Viral Diarrhea Infectious Virus Clone
CO5280138A1 (en) DAMAGED AND INNOCUTIVE VIRUSES OF THE VIRICA BOVINA DIARREA FOR IN MANAGING COWS
AR022250A1 (en) PHARMACEUTICAL CONTAINER OF USE FOR THE TREATMENT AND PREVENTION OF INFECTIONS BY THE VIRUS OF HEPATITIS B, PROCEDURE FOR THE TREATMENT OF PATIENTS OR PATIENTS SUSCEPTIBLE IN SUFFERING INFECTIONS BY THE VIRUS OF HEPATITIS B.
SE9604581D0 (en) An agent against cancer and virus infections
BR0209145A (en) Smallpox vaccine
ES2074965B1 (en) RECOMBINANT MUTANT VIRUSES OF INFECTIOUS BOVINE RHINOTRACHEITIS AND VACCINES THAT CONTAIN IT.
WO1999061011A3 (en) Use of a medicine containing a quantity of tyrothricine for the treatment of viral infections
ES2084587T3 (en) NON-REVERTING RNA VIRUSES.
RS20120367A2 (en) Methods and mixtures for treatment of viral hepatitis c

Legal Events

Date Code Title Description
FC Refusal